Clinical Trials Browser

OTHER × Anemia, Refractory, with Excess of Blasts × eltrombopag × Clear all

NCT01772420 2023-07-27

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Phase 2 Completed

52 enrolled 21 charts

Classical hematologyOther hematologic neoplasm

Anemia, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic